New York, United States –
As per the report published by The Brainy Insights, the global custom antibody market is expected to grow from USD 403.04 million in 2021 to USD 960.51 million by 2030, at a CAGR of 10.13% during the forecast period 2022-2030. North America region emerged as the largest market for the global custom antibody market, with a 43.36% share of the market revenue in 2021. The increase in government support in infection control & management and the rise in usage for treatment of various chronic diseases are propelling the market’s growth in this region. Additionally, the increasing research activity & funding and quality concerns over catalog antibodies are helping to drive market growth in this region. In addition, the Asia Pacific region is expected to show the fastest CAGR growth over the projection period due to increased R&D activities undertaken by academic institutions.
Discover market potential and make informed business decisions based on qualitative and quantitative evidence highlighted in The Brainy Insights reports- Request a sample report
The custom antibody market refers to the industry involved in the production and supply of custom-made antibodies for scientific research, diagnostics, and therapeutic applications. Custom antibodies are designed and produced to target specific antigens or proteins of interest, providing researchers with valuable tools for various laboratory and clinical applications.
Here are some key aspects of the custom antibody market:
Custom Antibody Production: Custom antibodies are typically produced through immunization methods. Animals, such as rabbits, mice, goats, or chickens, are immunized with the target antigen to elicit an immune response. The antibodies generated from these animals are then purified and validated for specificity and affinity.
Polyclonal and Monoclonal Antibodies: There are two primary types of custom antibodies: polyclonal and monoclonal antibodies. Polyclonal antibodies are derived from the serum of immunized animals and consist of a mixture of antibodies that recognize different epitopes on the target antigen. Monoclonal antibodies are produced by isolating a specific antibody-producing cell and cloning it to generate identical antibodies.
Applications: Custom antibodies have a wide range of applications in scientific research, diagnostics, and therapeutics. They are used in techniques such as Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), enzyme-linked immunosorbent assays (ELISAs), flow cytometry, and more. Custom antibodies are also utilized in drug discovery, biomarker identification, and the development of therapeutic antibodies.
Customization Options: The custom antibody market offers various customization options to meet specific research needs. This includes selecting the host species, antigen design, immunization strategy, antibody purification methods, and conjugation to different labels or tags for detection purposes.
Academic and Industrial Demand: The demand for custom antibodies comes from both academic researchers and industrial organizations. Academic researchers utilize custom antibodies for basic research, while biotechnology and pharmaceutical companies rely on them for drug development, diagnostic kits, and therapeutic applications.
Market Players: The custom antibody market includes a diverse range of companies and service providers that specialize in antibody production and related services. These companies offer custom antibody production, purification, characterization, and validation services to researchers and organizations worldwide.
Advancements in Antibody Technologies: The custom antibody market continues to evolve with advancements in antibody technologies, including recombinant antibody production, phage display, and antibody engineering techniques. These advancements enhance antibody specificity, affinity, and versatility, expanding the possibilities for custom antibody applications.
The custom antibody market is driven by the increasing demand for specific and reliable research tools, the growing emphasis on personalized medicine, and the expanding fields of biotechnology and therapeutics. The market is highly competitive, with numerous companies offering custom antibody services and solutions.
Leading companies in the industry include Genscript, Merck Group, Thermo Fisher Scientific Inc., Rockland Immunochemicals Inc., Abcam PLC, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Promab Biotechnologies, Inc., Biolegend, Inc., Innovagen Ab., Proteogenix, and among others which are offering greater opportunities and are continuously focused on new product developments and venture capital investments to obtain market share.
The research area segment is divided into neurobiology, infectious diseases, oncology, cardiovascular disease, immunology, stem cells, and others. The oncology segment led the market with a market share of 28.15% in 2021. This growth is attributed to the raised demand for advanced and innovative technologies in the healthcare industry. The type segment is divided into polyclonal antibodies, monoclonal antibodies, recombinant antibodies, and others. The monoclonal antibodies segment led the market with a market share of 29.32% in 2021. This growth is attributed to the presence of well-established healthcare infrastructure along with the increase in R&D activities in genomics.The source segment is divided into rabbits, mice, and others. The monoclonal antibodies segment led the market with a market share of 41.27% in 2021. This growth is attributed to the growing number of collaborations between industries. The service segment is divided into antibody production & purification, antibody development, and antibody fragmentation & labeling. The antibody development segment led the market with a market share of 43.35% in 2021. This growth is attributed to the availability of technologically advanced diagnostic and therapeutic products utilizing research antibodies. The end-user segment is divided into contract research organizations, pharmaceutical & biotechnology companies, and academic & research institutes. The pharmaceutical & biotechnology companies segment led the market with a market share of 41.24% in 2021. This growth is attributed to the rising research in proteomics & genomics.
The increasing healthcare awareness, technological advancement, and medical tourism propel the custom antibody market’s growth. Further, a proliferation in research and activity-especially in the life sciences industry is helping to stimulate the growth of the custom antibody market. In addition, the rapidly increasing awareness regarding the effectiveness of the drugs among patients and the necessity for effective & innovative therapies also boosts the market growth.
Related Report:
The global cell culture market is expected to grow from USD 20.96 billion in 2022 to USD 56.19 billion by 2030, at a CAGR of 13.12% during the forecast period 2022-2030.
Media Contact
Avinash D
Organization: The Brainy Insights
Phone: +1-315-215-1633
Email: sales@thebrainyinsights.com
Web: www.thebrainyinsights.com